DTL
ADMA icon

Dynamic Technology Lab’s ADMA Biologics ADMA Stock Holding History

Dynamic Technology Lab’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15,920
Closed -$290K – 780
2025
Q2 		$290K Buy
+15,920
New +$325K 0.04% 694
2023
Q4 		– Sell
-31,975
Closed -$114K – 997
2023
Q3 		$114K Buy
31,975
+10,720
+50% +$41.3K 0.01% 853
2023
Q2 		$78K Buy
21,255
+9,542
+81% +$35.4K 0.01% 916
2023
Q1 		$39K Buy
+11,713
New +$40.5K ﹤0.01% 1007
2021
Q2 		– Sell
-31,982
Closed -$56K – 1087
2021
Q1 		$56K Buy
31,982
+11,420
+56% +$26.1K 0.01% 1082
2020
Q4 		$40K Sell
20,562
-22,225
-52% -$46.7K 0.01% 933
2020
Q3 		$102K Buy
42,787
+5,218
+14% +$14.3K 0.02% 890
2020
Q2 		$110K Buy
+37,569
New +$108K 0.02% 879

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
SHCM
Sachem Head Capital Management New York $4.82B AUM 73.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Dynamic Technology Lab's ADMA Position: Q3 2025 in Review

Dynamic Technology Lab sold out of ADMA Biologics (ADMA) in Q3 2025, closing a stake of 15,920 shares — an estimated $290K sold.

Dynamic Technology Lab first reported a position in ADMA in Q2 2020 and held it in 8 quarters. The position peaked at $290K in Q2 2025. 365 funds tracked by Wall St. Rank hold ADMA as of Q3 2025.

  • Dynamic Technology Lab reported no remaining ADMA Biologics position as of Q3 2025 after selling out during the quarter.
  • Dynamic Technology Lab sold 15,920 ADMA Biologics shares in Q3 2025, an estimated $290K.
  • Dynamic Technology Lab first reported a position in ADMA Biologics in Q2 2020 and held it in 8 quarters.
  • Dynamic Technology Lab's ADMA Biologics position peaked at $290K in Q2 2025.
  • 365 funds tracked by Wall St. Rank held ADMA Biologics as of Q3 2025.

Based on Dynamic Technology Lab's 13F filing for Q3 2025, filed 13 Nov 2025.